In the NSCLC cell lines examined, we predicted pathogenic ND mutations based on various criteria: the ND5 G13708A mutation in H358 cells and the ND4 G11453A mutation in RERF-Lc-Ad2 cells. This evidence concerns the gene MT-ND5 and non-small cell lung carcinoma.